†Compared to conventional methods/electrosurgery.
‡Used in over 25 million procedures.
§23 out of 23 surgeons surveyed agreed.
1. Based on COGNOS and historical sales data, FY01–FY20. October 2019
2. Lee JS, Kim DG, Lee JW, et al. Usefulness of the LigaSure™ small jaw sealing device for breast reconstruction with a latissimus dorsi flap. J Plast Surg Hand Surg. 2019;53(5):295–300.
3. Chang YW, Kim HS, Jung SP, et al. Comparison of skin-sparing mastectomy using LigaSure™ Small Jaw and electrocautery. World J Surg Oncol. 2017;15(1):129.
4. Seki T, Hayashida T, Takahashi M, Jinno H, Kitagawa Y. A randomized controlled study comparing a vessel sealing system with the conventional technique in axillary lymph node dissection for primary breast cancer. Springerplus. 2016;5(1):1004.
5. Inoue Y, Yamashita N, Ueo H, et al. The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer. Anticancer Res. 2018;38(4):2359–2362.
6. Based on internal report #RE00114823, Validation labs: Surgeon evaluation of LigaSure™ exact dissector, nano-coated. July 18–26, 2017.
7. Based on internal test report #RE00153866, Comparison of the Harmonic Focus+™*shears, ThunderBeat™* open fine jaw, Voyant™* fine fusion, and LigaSure™* LF1212 vs. LigaSure™ LF2019 on the Valleylab™ FT10 and Valleylab™ LS10 energy platform and the 13 cm Sonicision™ curved jaw in an acute porcine study. January 2019.
©2023 Medtronic. All rights reserved, Medtronic. Medtronic logo and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 10/2022 - US-SE-2100385